Terry Riss, PhD – Global Strategic Marketing Manager Cell Health, Promega Corporation.
Dr. Riss received a PhD in Cell Biology from the University of Illinois in 1978 in the field of mammary gland biology. He did postdoctoral work at the University of Texas Medical School in Houston purifying growth factors involved with breast cancer and developing serum-free media formulations to implement bioassays. Dr. Riss moved to the Biotechnology division of Schering Plough in 1988 to develop interleukin/cytokine bioassays to support investigational new drug filings. Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 and has held several R&D and Project Management positions. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and also lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death. Dr. Riss now serves as Global Strategic Marketing Manager, Cell Health involved in outreach educational training activities. Dr. Riss regularly participates in NIH study sections reviewing HTS grants and is co-editor of the cell culture assays section of the Assay Guidance Manual hosted by NIH.

Soulmaz Boroumand, PhD Center for Regenerative Medicine (CRM), Mayo Clinic
Dr. Soulmaz Boroumand is a post-doctoral fellow in the Center for Regenerative Medicine (CRM) at Mayo Clinic in Rochester Minnesota. Possessing degrees in Industrial and Commercial and Biotechnology (MSc) and Biomedical Sciences (PhD), she is equally accomplished in basic and translational science, alike. Her most significant contribution to the Van Cleve Cardiac Regeneration Research Program within the Center for Regenerative Medicine was her development and optimization of a shelf-stable purified exosome product for regenerative applications. Dr. Boroumand’s academic qualifications are uniquely complemented by a didactic foundation in and passion for regulatory science. In 2016, she was appointed as lead scientist of the program’s Good Manufacturing Practice (GMP)-grade Advanced Product Incubator (API) under supervision of the medical director.

Brian W. Jarecki, PhD – Technical Sales Consultant, Essen Bioscience – a Sartorius Company

Brian received his PhD from Indiana University in Pharmacology and Toxicology with a focus on pain perception. He then completed his postdoctoral fellowship at the University of Wisconsin-Madison in the Department of Neuroscience with an emphasis on ion channel biophysics. After finishing his postdoc, he took a position with Cellular Dynamics International as the primary scientific liaison in the Drug Discovery and Bioengineering business unit for the US sales team. He currently works for Essen Bioscience as a Technical Sales Consultant covering the Upper Midwest (WI, MN, MI, ND and SD) in support of their live-cell analysis system, IncuCyte.

 Kevin Kopish Sr. Strategic Marketing Manager, Cellular Analysis/Proteomics- Promega Corporation

In over nearly 15 years at Promega Corporation, Kevin has managed multiple product lines including imaging technologies and luminometers.  His current focus is in the development of bioluminescent reporters to help answer emerging questions in the life sciences. Most recently he has helped bring to market a number of assay platforms based on NanoLuc luciferase, with applications for measuring protein: protein interactions in live cells, understanding drug binding and kinetics in live cells, and protein tagging using genome engineering technologies.  Kevin graduated from the University of Wisconsin with a degree in Molecular Biology.

Chris Parker, Biotechnology Consultant